 | • レポートコード：MRC2312A018 • 出版社/出版日：Transparency Market Research / 2023年8月2日 • レポート形態：英文、PDF、309ページ • 納品方法：Eメール（納期：要問合せ） • 産業分類：医療機器 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 胸腔ドレナージ機器市場 - レポートの範囲TMRの調査レポート「世界の胸腔ドレナージ機器市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の胸腔ドレナージ機器市場の収益を提供しています。また、2023年から2031年までの世界の胸腔ドレナージ機器市場の複合年間成長率（CAGR %）も掲載しています。 本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、胸腔ドレナージ機器市場を理解しました。 二次調査には、インターネットソース、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界の胸腔ドレナージ機器市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは世界の胸腔ドレナージ機器市場における競争ダイナミクスの変化に光を投げかけています。これらは、既存の市場プレイヤーだけでなく、世界の胸腔ドレナージ機器市場への参入に関心のある企業にとっても貴重なツールとなります。 本レポートでは、世界の胸腔ドレナージ機器市場の競争状況について掘り下げています。世界の胸腔ドレナージ機器市場で事業を展開する主要プレイヤーを特定し、各プレイヤーを様々な属性でプロファイルしています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の胸腔ドレナージ機器市場におけるプレイヤーの属性です。 世界の胸腔ドレナージ機器市場レポートで回答された主な質問 - 予測期間中の全地域における胸腔ドレナージ機器の売上高/収益は？ - 世界の胸腔ドレナージ機器市場におけるビジネスチャンスは？ - 市場の主な促進要因、阻害要因、機会、脅威は？ - 予測期間中に最も速いCAGRで拡大する地域市場は？ - 2031年に世界で最も高い収益を上げると予測されるセグメントは？ - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？ - 世界市場で事業を展開する各企業の市場ポジションは？ 胸腔ドレナージ機器市場 - 調査目的と調査アプローチ 世界の胸腔ドレナージ機器市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフと表を適切に配置した網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化することで、読者に視覚的に訴えかけます。また、主要セグメントの過去と予測期間末の市場シェアの比較も可能です。 本レポートでは、世界の胸腔ドレナージ機器市場を製品、エンドユーザー、地域の観点から分析。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界胸腔ドレナージ機器市場への投資について十分な情報に基づいたビジネス上の意思決定を行うことができます。 |
1. 序論
2. 仮定・調査方法
3. エグゼクティブサマリー：世界の胸腔ドレナージ機器市場
4. 市場概要
5. 主要インサイト
6. 世界の胸腔ドレナージ機器市場分析・予測：製品別
7. 世界の胸腔ドレナージ機器市場分析・予測：用途別
8. 世界の胸腔ドレナージ機器市場分析・予測：エンドユーザー別
9. 世界の胸腔ドレナージ機器市場分析・予測：地域別
10. 北米の胸腔ドレナージ機器市場分析・予測
11. アメリカの胸腔ドレナージ機器市場分析・予測
12. ヨーロッパの胸腔ドレナージ機器市場分析・予測
13. ドイツの胸腔ドレナージ機器市場分析・予測
14. イギリスの胸腔ドレナージ機器市場分析・予測
15. フランスの胸腔ドレナージ機器市場分析・予測
16. スペインの胸腔ドレナージ機器市場分析・予測
17. アジア太平洋の胸腔ドレナージ機器市場分析・予測
18. 中南米の胸腔ドレナージ機器市場分析・予測
19. 中東・アフリカの胸腔ドレナージ機器市場分析・予測
20. 競争状況
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chest Drainage Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Development
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Chest Drainage Devices Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Key Product/Brand Analysis
5.4. COVID-19 Pandemic Impact on Industry
6. Global Chest Drainage Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product, 2017-2031
6.3.1. Thoracic Drainage Systems
6.3.1.1. Analog
6.3.1.2. Digital
6.3.2. Trocar Drains
6.3.3. Unsecured Needles
6.3.4. Secured Needles
6.3.5. Pleural Drainage Catheters
6.3.5.1. PVC
6.3.5.2. Others
6.3.6. Thoracic Drainage Kits
6.4. Market Attractiveness Analysis, by Product
7. Global Chest Drainage Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Thoracic Surgeries & Pulmonology
7.3.2. Cardiac Surgeries
7.3.3. General Intensive Care & Emergency Medicine
7.3.4. Infectious Diseases
7.3.5. Oncology & Pain Management
7.3.6. Military/Damage Control/Disaster Medicine
7.4. Market Attractiveness Analysis, by Application
8. Global Chest Drainage Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals & Specialty Clinics
8.3.2. Urgent Care or Outpatient Care
8.3.3. Ambulatory Surgical Centers
8.3.4. Military Medical Facilities
8.3.5. Ambulance Services
8.4. Market Attractiveness Analysis, by End-user
9. Global Chest Drainage Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Chest Drainage Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product, 2017-2031
10.2.1. Thoracic Drainage Systems
10.2.1.1. Analog
10.2.1.2. Digital
10.2.2. Trocar Drains
10.2.3. Unsecured Needles
10.2.4. Secured Needles
10.2.5. Pleural Drainage Catheters
10.2.5.1. PVC
10.2.5.2. Others
10.2.6. Thoracic Drainage Kits
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Thoracic Surgeries & Pulmonology
10.3.2. Cardiac Surgeries
10.3.3. General Intensive Care & Emergency Medicine
10.3.4. Infectious Diseases
10.3.5. Oncology & Pain Management
10.3.6. Military/Damage Control/Disaster Medicine
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals & Specialty Clinics
10.4.2. Urgent Care or Outpatient Care
10.4.3. Ambulatory Surgical Centers
10.4.4. Military Medical Facilities
10.4.5. Ambulance Services
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. U.S. Chest Drainage Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product, 2017-2031
11.2.1. Thoracic Drainage Systems
11.2.1.1. Analog
11.2.1.2. Digital
11.2.2. Trocar Drains
11.2.3. Unsecured Needles
11.2.4. Secured Needles
11.2.5. Pleural Drainage Catheters
11.2.5.1. PVC
11.2.5.2. Others
11.2.6. Thoracic Drainage Kits
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Thoracic Surgeries & Pulmonology
11.3.2. Cardiac Surgeries
11.3.3. General Intensive Care & Emergency Medicine
11.3.4. Infectious Diseases
11.3.5. Oncology & Pain Management
11.3.6. Military/Damage Control/Disaster Medicine
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals & Specialty Clinics
11.4.2. Urgent Care or Outpatient Care
11.4.3. Ambulatory Surgical Centers
11.4.4. Military Medical Facilities
11.4.5. Ambulance Services
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Application
11.5.3. By End-user
12. Europe Chest Drainage Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product, 2017-2031
12.2.1. Thoracic Drainage Systems
12.2.1.1. Analog
12.2.1.2. Digital
12.2.2. Trocar Drains
12.2.3. Unsecured Needles
12.2.4. Secured Needles
12.2.5. Pleural Drainage Catheters
12.2.5.1. PVC
12.2.5.2. Others
12.2.6. Thoracic Drainage Kits
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Thoracic Surgeries & Pulmonology
12.3.2. Cardiac Surgeries
12.3.3. General Intensive Care & Emergency Medicine
12.3.4. Infectious Diseases
12.3.5. Oncology & Pain Management
12.3.6. Military/Damage Control/Disaster Medicine
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals & Specialty Clinics
12.4.2. Urgent Care or Outpatient Care
12.4.3. Ambulatory Surgical Centers
12.4.4. Military Medical Facilities
12.4.5. Ambulance Services
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. Germany
12.5.2. U.K.
12.5.3. France
12.5.4. Spain
12.5.5. Italy
12.5.6. Rest of Europe
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Germany Chest Drainage Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product, 2017-2031
13.2.1. Thoracic Drainage Systems
13.2.1.1. Analog
13.2.1.2. Digital
13.2.2. Trocar Drains
13.2.3. Unsecured Needles
13.2.4. Secured Needles
13.2.5. Pleural Drainage Catheters
13.2.5.1. PVC
13.2.5.2. Others
13.2.6. Thoracic Drainage Kits
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Thoracic Surgeries & Pulmonology
13.3.2. Cardiac Surgeries
13.3.3. General Intensive Care & Emergency Medicine
13.3.4. Infectious Diseases
13.3.5. Oncology & Pain Management
13.3.6. Military/Damage Control/Disaster Medicine
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals & Specialty Clinics
13.4.2. Urgent Care or Outpatient Care
13.4.3. Ambulatory Surgical Centers
13.4.4. Military Medical Facilities
13.4.5. Ambulance Services
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Application
13.5.3. By End-user
14. U.K. Chest Drainage Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product, 2017-2031
14.2.1. Thoracic Drainage Systems
14.2.1.1. Analog
14.2.1.2. Digital
14.2.2. Trocar Drains
14.2.3. Unsecured Needles
14.2.4. Secured Needles
14.2.5. Pleural Drainage Catheters
14.2.5.1. PVC
14.2.5.2. Others
14.2.6. Thoracic Drainage Kits
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Thoracic Surgeries & Pulmonology
14.3.2. Cardiac Surgeries
14.3.3. General Intensive Care & Emergency Medicine
14.3.4. Infectious Diseases
14.3.5. Oncology & Pain Management
14.3.6. Military/Damage Control/Disaster Medicine
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals & Specialty Clinics
14.4.2. Urgent Care or Outpatient Care
14.4.3. Ambulatory Surgical Centers
14.4.4. Military Medical Facilities
14.4.5. Ambulance Services
14.5. Market Attractiveness Analysis
14.5.1. By Product
14.5.2. By Application
14.5.3. By End-user
15. France Chest Drainage Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value & Volume Forecast, by Product, 2017-2031
15.2.1. Thoracic Drainage Systems
15.2.1.1. Analog
15.2.1.2. Digital
15.2.2. Trocar Drains
15.2.3. Unsecured Needles
15.2.4. Secured Needles
15.2.5. Pleural Drainage Catheters
15.2.5.1. PVC
15.2.5.2. Others
15.2.6. Thoracic Drainage Kits
15.3. Market Value Forecast, by Application, 2017-2031
15.3.1. Thoracic Surgeries & Pulmonology
15.3.2. Cardiac Surgeries
15.3.3. General Intensive Care & Emergency Medicine
15.3.4. Infectious Diseases
15.3.5. Oncology & Pain Management
15.3.6. Military/Damage Control/Disaster Medicine
15.4. Market Value Forecast, by End-user, 2017-2031
15.4.1. Hospitals & Specialty Clinics
15.4.2. Urgent Care or Outpatient Care
15.4.3. Ambulatory Surgical Centers
15.4.4. Military Medical Facilities
15.4.5. Ambulance Services
15.5. Market Attractiveness Analysis
15.5.1. By Product
15.5.2. By Application
15.5.3. By End-user
16. Spain Chest Drainage Devices Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value & Volume Forecast, by Product, 2017-2031
16.2.1. Thoracic Drainage Systems
16.2.1.1. Analog
16.2.1.2. Digital
16.2.2. Trocar Drains
16.2.3. Unsecured Needles
16.2.4. Secured Needles
16.2.5. Pleural Drainage Catheters
16.2.5.1. PVC
16.2.5.2. Others
16.2.6. Thoracic Drainage Kits
16.3. Market Value Forecast, by Application, 2017-2031
16.3.1. Thoracic Surgeries & Pulmonology
16.3.2. Cardiac Surgeries
16.3.3. General Intensive Care & Emergency Medicine
16.3.4. Infectious Diseases
16.3.5. Oncology & Pain Management
16.3.6. Military/Damage Control/Disaster Medicine
16.4. Market Value Forecast, by End-user, 2017-2031
16.4.1. Hospitals & Specialty Clinics
16.4.2. Urgent Care or Outpatient Care
16.4.3. Ambulatory Surgical Centers
16.4.4. Military Medical Facilities
16.4.5. Ambulance Services
16.5. Market Attractiveness Analysis
16.5.1. By Product
16.5.2. By Application
16.5.3. By End-user
17. Asia Pacific Chest Drainage Devices Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value & Volume Forecast, by Product, 2017-2031
17.2.1. Thoracic Drainage Systems
17.2.1.1. Analog
17.2.1.2. Digital
17.2.2. Trocar Drains
17.2.3. Unsecured Needles
17.2.4. Secured Needles
17.2.5. Pleural Drainage Catheters
17.2.5.1. PVC
17.2.5.2. Others
17.2.6. Thoracic Drainage Kits
17.3. Market Value Forecast, by Application, 2017-2031
17.3.1. Thoracic Surgeries & Pulmonology
17.3.2. Cardiac Surgeries
17.3.3. General Intensive Care & Emergency Medicine
17.3.4. Infectious Diseases
17.3.5. Oncology & Pain Management
17.3.6. Military/Damage Control/Disaster Medicine
17.4. Market Value Forecast, by End-user, 2017-2031
17.4.1. Hospitals & Specialty Clinics
17.4.2. Urgent Care or Outpatient Care
17.4.3. Ambulatory Surgical Centers
17.4.4. Military Medical Facilities
17.4.5. Ambulance Services
17.5. Market Value Forecast, by Country/Sub-region, 2017-2031
17.5.1. China
17.5.2. Japan
17.5.3. India
17.5.4. Australia & New Zealand
17.5.5. Rest of Asia Pacific
17.6. Market Attractiveness Analysis
17.6.1. By Product
17.6.2. By Application
17.6.3. By End-user
17.6.4. By Country/Sub-region
18. Latin America Chest Drainage Devices Market Analysis and Forecast
18.1. Introduction
18.1.1. Key Findings
18.2. Market Value & Volume Forecast, by Product, 2017-2031
18.2.1. Thoracic Drainage Systems
18.2.1.1. Analog
18.2.1.2. Digital
18.2.2. Trocar Drains
18.2.3. Unsecured Needles
18.2.4. Secured Needles
18.2.5. Pleural Drainage Catheters
18.2.5.1. PVC
18.2.5.2. Others
18.2.6. Thoracic Drainage Kits
18.3. Market Value Forecast, by Application, 2017-2031
18.3.1. Thoracic Surgeries & Pulmonology
18.3.2. Cardiac Surgeries
18.3.3. General Intensive Care & Emergency Medicine
18.3.4. Infectious Diseases
18.3.5. Oncology & Pain Management
18.3.6. Military/Damage Control/Disaster Medicine
18.4. Market Value Forecast, by End-user, 2017-2031
18.4.1. Hospitals & Specialty Clinics
18.4.2. Urgent Care or Outpatient Care
18.4.3. Ambulatory Surgical Centers
18.4.4. Military Medical Facilities
18.4.5. Ambulance Services
18.5. Market Value Forecast, by Country/Sub-region, 2017-2031
18.5.1. Brazil
18.5.2. Mexico
18.5.3. Rest of Latin America
18.6. Market Attractiveness Analysis
18.6.1. By Product
18.6.2. By Application
18.6.3. By End-user
18.6.4. By Country/Sub-region
19. Middle East & Africa Chest Drainage Devices Market Analysis and Forecast
19.1. Introduction
19.1.1. Key Findings
19.2. Market Value & Volume Forecast, by Product, 2017-2031
19.2.1. Thoracic Drainage Systems
19.2.1.1. Analog
19.2.1.2. Digital
19.2.2. Trocar Drains
19.2.3. Unsecured Needles
19.2.4. Secured Needles
19.2.5. Pleural Drainage Catheters
19.2.5.1. PVC
19.2.5.2. Others
19.2.6. Thoracic Drainage Kits
19.3. Market Value Forecast, by Application, 2017-2031
19.3.1. Thoracic Surgeries & Pulmonology
19.3.2. Cardiac Surgeries
19.3.3. General Intensive Care & Emergency Medicine
19.3.4. Infectious Diseases
19.3.5. Oncology & Pain Management
19.3.6. Military/Damage Control/Disaster Medicine
19.4. Market Value Forecast, by End-user, 2017-2031
19.4.1. Hospitals & Specialty Clinics
19.4.2. Urgent Care or Outpatient Care
19.4.3. Ambulatory Surgical Centers
19.4.4. Military Medical Facilities
19.4.5. Ambulance Services
19.5. Market Value Forecast, by Country/Sub-region, 2017-2031
19.5.1. Brazil
19.5.2. Mexico
19.5.3. Rest of Latin America
19.6. Market Attractiveness Analysis
19.6.1. By Product
19.6.2. By Application
19.6.3. By End-user
19.6.4. By Country/Sub-region
20. Competition Landscape
20.1. Market Player – Competition Matrix (By Tier and Size of companies)
20.2. Market Share Analysis By Company (2022)
20.3. List of Key Players by Product Category
20.4. Company Profiles
20.4.1. ATMOS MedizinTechnik GmbH & Co. KG
20.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.1.2. Product Portfolio
20.4.1.3. Financial Overview
20.4.1.4. SWOT Analysis
20.4.1.5. Strategic Overview
20.4.2. Becton, Dickinson and Company (BD)
20.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.2.2. Product Portfolio
20.4.2.3. Financial Overview
20.4.2.4. SWOT Analysis
20.4.2.5. Strategic Overview
20.4.3. Cardinal Health, Inc.
20.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.3.2. Product Portfolio
20.4.3.3. Financial Overview
20.4.3.4. SWOT Analysis
20.4.3.5. Strategic Overview
20.4.4. Cook Medical
20.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.4.2. Product Portfolio
20.4.4.3. Financial Overview
20.4.4.4. SWOT Analysis
20.4.4.5. Strategic Overview
20.4.5. Getinge AB
20.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.5.2. Product Portfolio
20.4.5.3. Financial Overview
20.4.5.4. SWOT Analysis
20.4.5.5. Strategic Overview
20.4.6. ICU Medical, Inc.
20.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.6.2. Product Portfolio
20.4.6.3. Financial Overview
20.4.6.4. SWOT Analysis
20.4.6.5. Strategic Overview
20.4.7. Medela AG
20.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.7.2. Product Portfolio
20.4.7.3. Financial Overview
20.4.7.4. SWOT Analysis
20.4.7.5. Strategic Overview
20.4.8. Medtronic
20.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.8.2. Product Portfolio
20.4.8.3. Financial Overview
20.4.8.4. SWOT Analysis
20.4.8.5. Strategic Overview
20.4.9. Redax S.p.a.
20.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.9.2. Product Portfolio
20.4.9.3. Financial Overview
20.4.9.4. SWOT Analysis
20.4.9.5. Strategic Overview
20.4.10. Rocket Medical plc.
20.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.10.2. Product Portfolio
20.4.10.3. Financial Overview
20.4.10.4. SWOT Analysis
20.4.10.5. Strategic Overview
20.4.11. Sinapi Biomedical
20.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.11.2. Product Portfolio
20.4.11.3. Financial Overview
20.4.11.4. SWOT Analysis
20.4.11.5. Strategic Overview
20.4.12. Teleflex Incorporated
20.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.12.2. Product Portfolio
20.4.12.3. Financial Overview
20.4.12.4. SWOT Analysis
20.4.12.5. Strategic Overview
20.4.13. Utah Medical Products, Inc.
20.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.13.2. Product Portfolio
20.4.13.3. Financial Overview
20.4.13.4. SWOT Analysis
20.4.13.5. Strategic Overview
20.4.14. Vygon SAS
20.4.14.1. Company Overview (HQ, Business Segments, Employee Strength)
20.4.14.2. Product Portfolio
20.4.14.3. Financial Overview
20.4.14.4. SWOT Analysis
20.4.14.5. Strategic Overview
